VALYSTR · Stock research
Listed on NasdaqGM. What the market is pricing into ANI Pharmaceuticals, Inc. (ANIP) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceutical Preparations · market value about $1.7B · P/E 15.6 · revenue $978M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows